ActiveCare Retains DelMorgan & Co. as Financial Advisor to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ActiveCare Retains DelMorgan & Co. as Financial Advisor to Explore Strategic Alternatives

OREM, Utah, Dec. 3, 2013 (GLOBE NEWSWIRE) -- ActiveCare, Inc. (OTCBB:ACAR) (www.activecare.com), a leader in diabetes management and wellness services, announced today that it has retained DelMorgan & Co. (www.delmorganco.com), an internationally recognized investment banking firm, as its financial advisor to advise ActiveCare on its strategic alternatives, including growth capital investments, possible acquisitions or divestitures, joint ventures or other strategic alliances, and other initiatives to deliver shareholder value.

David Derrick, Chairman and CEO of ActiveCare, stated, "We are very excited about our engagement of DelMorgan & Co. Their experience and professionalism in capital raising and M&A will help us analyze ActiveCare's strategic options and pursue growth through transactions that will benefit our company and our shareholders."

Rob Delgado, Chairman of DelMorgan & Co., commented, "We are pleased to be working with ActiveCare. They have developed unique and patented solutions for diabetes management that work, and their recent growth is a testament to the attractiveness of the ActiveCare approach to health plans, third party administrators and employers across the country." Mr. Delgado noted, "ActiveCare has grown its diabetes management business over the past 18 months from essentially nothing to monitoring over 30,000 diabetic members for almost 100 employers. But the potential for growth is vast. With over 25 million diabetics and another 79 million pre-diabetics in the United States costing over $245 billion per year – 33% of the nation's total healthcare costs – there is tremendous market demand for an approach that has been shown to significantly reduce those costs. ActiveCare has that solution."

Neil Morganbesser, President & CEO of DelMorgan & Co., added, "We are very much looking forward to engaging with ActiveCare and helping them realize their growth potential. With a substantial sales pipeline and the need to fund working capital for growth, solving ActiveCare's short-term financial challenges should unlock the opportunity for explosive future expansion and substantial profitability. These are high-class problems confronted by many successful companies who have demonstrated 'proof of concept' in the market and are poised to grow rapidly. Our goal is to help ensure that capital is available for growth and the company can execute on its business plan."

About ActiveCare

ActiveCare, Inc. provides patented diabetes and chronic disease management and wellness solutions that increase visibility, lower costs and provide real-time care for members resulting in improved outcomes. Utilizing state-of-the-art meters with embedded cellular technology, highly trained CareSpecialists can intervene in real-time and provide members with the support needed to control their disease 24 hours a day, every day.  Headquartered in Orem, Utah and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare's solution is revolutionizing the way employers, individuals and their health plans monitor chronic disease.  To learn more about ActiveCare, Inc., visit the website at www.activecare.com.

About DelMorgan & Co.

DelMorgan & Co. (www.delmorganco.com) is an internationally recognized investment bank and financial advisor. With over 150 years of combined experience and over $250 billion in successfully completed transactions, the professionals at DelMorgan & Co. provide world-class financial advice and assistance to companies, institutions, governments and individuals around the world. 

Safe Harbor

ActiveCare has not made any decision to enter into a transaction, and there can be no assurance that ActiveCare will enter into a transaction in the future. ActiveCare does not plan to disclose or comment on developments regarding the strategic alternatives review process until it is complete or until further disclosure is appropriate.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding ActiveCare's expectations with respect to strategic opportunities and possible future transactions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Readers of this press release are referred to the Company's filings with the Securities and Exchange Commission, including the Company's reports on Form 10-K, Forms 10-Q and Forms 8-K for further discussions of factors that could affect the Company's business and its future results. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. The Company assumes no obligation to update forward-looking statements if conditions or management's estimates or opinions should change.

Further Information

For further information, contact Rob Delgado or Neil Morganbesser at DelMorgan & Co. at (310) 319-2000 or visit www.activecare.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Short Term Shop Hits $500M in Airbnb Sales Milestone

Updated Category News Views 7

Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...

Continue Reading
Saddleback's Bold Doula Program: A Game Changer

Updated Category News Views 8

Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...

Continue Reading
Arbor Scientia Snags Second Consecutive BASA Win

Updated Category News Views 7

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options

Updated Category News Views 2

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

Continue Reading
Florida Leaders Set Sights on Top 10 Economy by 2030

Updated Category News Views 13

Florida's Ambitious Economic Goals When someone floats the idea of a state's economy cracking the top 10 globally by the year 2030, you've got to wonder if it's all sunshine and rainbows, or if there's some serious groundwork being laid. The Florida Chamber Foundation seems to think it's achievable. As the end of October rolls around, they're throwing the 2026 Future of...

Continue Reading
CourseArc Partners with Colleges for ADA Compliance

Updated Category News Views 3

CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...

Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M

Updated Category News Views 0

Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...

Continue Reading
MSA Safety to Reveal Q3 2026 Earnings on Nov. 3

Updated Category News Views 1

MSA Gears Up for Q3 Earnings Call—Why It Matters At the crack of dawn on November 3, 2026, MSA Safety Incorporated (NYSE: MSA) is set to unravel the latest updates on their financial frontline. For those keeping a sharp eye on the safety gear behemoth, this isn’t just another earnings call—it's the kind of event that can make or break confidence in their stock....

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 6

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
VIVIFY and ELISIUM Plan Hydrogen-Powered City

Updated Category News Views 4

Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breakthrough: MTX-201 Data Unveiled at Congress

Updated Category News Views 159

Exciting Developments from Mozart Therapeutics Recent findings from Mozart Therapeutics shine a spotlight on MTX-201, a groundbreaking bispecific antibody designed to treat inflammatory bowel disease (IBD). This innovative therapy selectively binds to CD8 regulatory T cells (Treg), with the potential to effectively eliminate pathogenic CD4 T cells and lessen inflammation,...

Continue Reading
Arixa Capital Celebrates Major Loan Milestone and Expansion

Updated Category News Views 162

Arixa Capital Achieves New Heights in Loan Originations Arixa Capital, a prominent private real estate lender, has officially crossed the impressive milestone of over $7 billion in total loan originations since its establishment. This remarkable achievement underscores the firm's commitment to providing flexible and reliable financing solutions to real estate...

Continue Reading
Synaffix Partners with Illumina to Advance DNA Sequencing Tech

Updated Category News Views 257

Synaffix and Illumina Join Forces for Breakthrough Technologies Synaffix B.V., a prominent biotechnology company renowned for its innovative clinical-stage bioconjugation platform technology, has announced a licensing agreement with Illumina, Inc., a leader in DNA sequencing technologies. This agreement allows Illumina access to Synaffix's patented metal-free click...

Continue Reading
Bristol Myers Squibb Gains Approval for Opdivo and Yervoy Combo

Updated Category News Views 145

Bristol Myers Squibb Gaining Traction in Colorectal Cancer Treatment Bristol Myers Squibb (NYSE: BMY) has recently secured a significant win by obtaining approval from the European Commission (EC) for its leading immunotherapy combinations. This approval is specifically for the use of Opdivo (nivolumab) combined with Yervoy (ipilimumab) as a first-line treatment option...

Continue Reading
Hillary F. Blackburn Joins ACIP as First Pharmacist Member

Updated Category News Views 359

Hillary F. Blackburn's Significant New Role The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have made an important announcement. They have appointed Hillary F. Blackburn, PharmD, MBA, as the first pharmacist voting member of the Advisory Committee on Immunization Practices (ACIP). This historic appointment...

Continue Reading